Related Experiment Video
Updated: Jan 14, 2026

06:27
Use of a Monocyte Monolayer Assay to Evaluate Fcγ Receptor-mediated Phagocytosis
Published on: January 2, 2017
18.7K
Clinical Utility of Monoclonal Gammopathy Testing in the Evaluation of Anemia
Mackenzie D Maberry1, Caleb J Smith2, Ronald S Go2
1Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
American Journal of Hematology
|October 23, 2025
Abstract:
Descriptive graph of all patients tested in this cohort who were found to have new MG diagnoses through testing (11.8%), and the percentage of patients with a clinically significant monoclonal protein test (0.4%). Clinically significant tests were those that led to a new lymphoplasmacytic diagnosis or uncovered MG as the source of the patient's anemia for which they received monoclonal protein testing.

